Skip to content

Tinnitus and Cochlear Implants

Evaluation of Factors Predicting Tinnitus Outcomes Following Cochlear Implantation

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06085885
Acronym
TICIT
Enrollment
50
Registered
2023-10-17
Start date
2023-12-30
Completion date
2024-12-31
Last updated
2024-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus

Brief summary

Objectives of this study are to (1) Determine whether there are meaningful changes in tinnitus outcomes following cochlear implantation in adults with bilateral severe-to-profound hearing loss, (2) Determine the prevalence, nature, and severity of tinnitus before cochlear implantation, (3) Determine the incidence, nature, and changes in severity of tinnitus following cochlear implantation, and (4) Explore associations between tinnitus and changes in hearing, psychological health, cochlear implantation-related factors, and quality of life in cochlear implant recipients with and without tinnitus. Participants will be adults eligible to receive a unilateral cochlear implant on the National Health Service (NHS) in the United Kingdom (UK). Participants will undergo routine pre- and post-operative assessments as part of usual care, and complete online questionnaires before and after implantation to measure tinnitus and other health related factors. Mixed statistical methods will be used to characterise the sample and evaluate changes in the severity of tinnitus and patient-specific factors after implantation.

Detailed description

Primary objective: Determine whether there are meaningful changes in tinnitus outcomes following cochlear implantation in adults with bilateral severe-to-profound hearing loss. Secondary objectives: 1. Determine the prevalence, nature, and severity of tinnitus before cochlear implantation. 2. Determine the incidence, nature, and changes in severity of tinnitus following cochlear implantation. 3. Explore associations between tinnitus and changes in hearing, psychological health, cochlear implantation-related factors, and quality of life in cochlear implant recipients with and without tinnitus. Patient identification: Providers of cochlear implantation services on the National Health Service in the United Kingdom. The schedule of questionnaires will follow the schedule of routine clinical appointments as part of the cochlear implantation care pathway including a pre-operative baseline assessment, and five follow up assessments after the surgery to receive the cochlear implant, after the first cochlear implant activation appointment, and at routine 1-, 3- and 6-month appointments post-activation. The baseline questionnaires will require about 40 min to complete and follow up questionnaires about 15-30 min. Detailed analyses will be specified prospectively in a study analysis plan developed by the study team. Data analyses will be conducted by the study team with support from medical statisticians at the National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre (BRC). The software utilised for analyses may include Excel, SPSS, R or MATLAB. Mixed statistical methods will be used to characterise the sample and evaluate changes in the severity of tinnitus and patient-specific factors before and after implantation. Data analyses will include descriptive statistics, General/Generalised Linear Models (e.g., ANOVA, regression models) or non-parametric statistical methods where appropriate (e.g., Mann Whitney U test).

Interventions

DEVICECochlear implant

Cochlear implant

Sponsors

Nottingham University Hospitals NHS Trust
CollaboratorOTHER
University of Nottingham
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older. * Determined to be eligible for unilateral cochlear implantation. * Did not previously receive a cochlear implant in either ear. * Sufficient written or spoken English to participate in study activities. * Have access to internet or suitable device to complete online study questionnaires. * Able to give informed consent.

Exclusion criteria

* Significant difficulties preventing independent completion of study activities.

Design outcomes

Primary

MeasureTime frameDescription
Tinnitus characteristics and associated medical and sociodemographic factorsBefore cochlear implantation, two weeks after cochlear implantation, immediately after the activation of the cochlear implant, and one, three and six months after the activation of the cochlear implantThe European School for Interdisciplinary Tinnitus Research Screening Questionnaire (ESiT-SQ). This is a case history questionnaire without a numerical scoring system.
Tinnitus impactBefore cochlear implantation, two weeks after cochlear implantation, immediately after the activation of the cochlear implant, and one, three and six months after the activation of the cochlear implantTinnitus Functional Index (TFI). Maximum score: 250, higher score indicates greater tinnitus symptom severity
Patient healthBefore cochlear implantation, two weeks after cochlear implantation, and one, three and six months after the activation of the cochlear implantPatient Health Questionnaire (PHQ-9) scores can range from 0 to 27 with a higher score indicating more severe symptoms
AnxietyBefore cochlear implantation, two weeks after cochlear implantation, and one, three and six months after the activation of the cochlear implantGeneralised Anxiety Disorder Assessment (GAD-7) scored from 0 to 21, with a higher score indicating more severe anxiety
InsomniaBefore cochlear implantation, two weeks after cochlear implantation, and one, three and six months after the activation of the cochlear implantInsomnia Severity Index (ISI) scored 0 to 28 with a higher score indicating more severe insomnia
Life qualityBefore cochlear implantation, two weeks after cochlear implantation, and one, three and six months after the activation of the cochlear implantEuroQol Quality of Life Questionnaire (EQ-5D-5L) scored from 0 to 100, with a lower score indicating worse health
Hearing functionBefore cochlear implantation, two weeks after cochlear implantation, immediately after the activation of the cochlear implant, and one, three and six months after the activation of the cochlear implantSpeech, Spatial and Qualities of Hearing (SSQ-12) questionnaire scored 0-120, with a higher score indicating better hearing ability

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026